Meteoric Biopharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 24-10-2024
- Paid Up Capital ₹ 1.50 Cr
as on 24-10-2024
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 41.15 Cr
as on 24-10-2024
- Satisfied Charges ₹ 3.50 Cr
as on 24-10-2024
- Revenue 20.42%
(FY 2023)
- Profit 52.06%
(FY 2023)
- Ebitda 37.36%
(FY 2023)
- Net Worth 47.20%
(FY 2023)
- Total Assets 23.30%
(FY 2023)
About Meteoric Biopharmaceuticals
The Corporate was formerly known as Meteoric Exim Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.50 Cr.
The company currently has active open charges totaling ₹41.15 Cr. The company has closed loans amounting to ₹3.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Poonam Gupta and Gaurav Kaushik serve as directors at the Company.
- CIN/LLPIN
U51100GJ2006PTC048129
- Company No.
048129
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Meteoric Biopharmaceuticals Private Limited offer?
Meteoric Biopharmaceuticals Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Enzymes, Animal Medicines & Health Care, Veterinary Medicines, Nutraceuticals & Dietary Supplements, Weight Loss Supplement, Organic and Inorganic Solvents, Ketones, Soaps, Detergent Powder & Cakes, Detergent Raw Material.
Who are the key members and board of directors at Meteoric Biopharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Gupta  | Director | 13-Apr-2006 | Current |
| Gaurav Kaushik | Director | 30-Jun-2009 | Current |
Financial Performance and Corporate Structure Insights of Meteoric Biopharmaceuticals.
Meteoric Biopharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.42% increase. The company also saw a substantial improvement in profitability, with a 52.06% increase in profit. The company's net worth Soared by an impressive increase of 47.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meteoric Biopharmaceuticals?
In 2023, Meteoric Biopharmaceuticals had a promoter holding of 99.56% and a public holding of 0.44%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Panacea Phytoextracts Private LimitedActive 5 years 7 monthsPoonam Gupta and Gaurav Kaushik are mutual person
Meteoric Cosmeceutiicals Private LimitedActive 2 years 5 monthsPoonam Gupta and Gaurav Kaushik are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 03 Apr 2024 | ₹41.15 Cr | Open |
Others Creation Date: 20 Nov 2021 | ₹1.50 Cr | Satisfied |
Sidbi Creation Date: 21 Oct 2021 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Meteoric Biopharmaceuticals?
Meteoric Biopharmaceuticals has a workforce of 77 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meteoric Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meteoric Biopharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
